ARTICLE | Company News
Selecta, National Institutes of Health neurology news
August 23, 2010 7:00 AM UTC
Selecta received a $3 million grant through the BRDG-SPAN program from NIH's National Institute on Drug Abuse (NIDA) to develop a therapeutic nicotine vaccine for smoking cessation. Selecta is using i...